Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aim Immunotech, Algernon, Ascentage, Biocryst, Capricor, Celltrion, Curevac, Edesa, Equillium, Imago, Marinomed, Moderna, Neoimmunetech, Novavax, Reithera.